12936 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2324)
  9. Epidemiology and Biostatistics (1997)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T-cell imaging to noninvasively monitor adoptive T-cell therapy for thoracic malignancies
    Meeting Abstract

    Villena-Vargas, J.; Rodriguez, L. A.; Moroz, M.; Cherkassky, L.; Rusch, V. W.; Sadelain, M.; Ponomarev, V.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • GITR pathway activation abrogates tumor immune suppression through loss of regulatory T-cell lineage stability
    Journal Article

    Schaer, D. A.; Budhu, S.; Liu, C.; Bryson, C.; Malandro, N.; Cohen, A.; Zhong, H.; Yang, X.; Houghton, A. N.; Merghoub, T.; more...
    Cancer Immunology Research (2013)

    Fulltext@MSK | Save
  • Enhancement of tumor-reactive cytotoxic CD4(+) T-cell responses after ipilimumab treatment in four advanced melanoma patients
    Journal Article

    Kitano, S.; Tsuji, T.; Liu, C.; Hirschhorn-Cymerman, D.; Kyi, C.; Mu, Z.; Allison, J. P.; Gnjatic, S.; Yuan, J. D.; Wolchok, J. D.
    Cancer Immunology Research (2013)

    Fulltext@MSK | Save
  • Effect of adjuvant trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-positive breast cancer treated with post- mastectomy radiation therapy
    Meeting Abstract

    Lanning, R. M.; Riaz, N.; Morrow, M.; Moo, T. A.; El-Tamer, M.; Krause, K.; Chen, Y.; Pei, X.; Powell, S. N.; Ho, A. Y.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Lineage-dependent functional organization of neocortical interneurons
    Meeting Abstract

    Zhang, X. J.; Shi, S. H.
    Society for Neuroscience Abstract Viewer and Itinerary Planner (2013)

    Fulltext@MSK | Save
  • An addiction-associated intronic SNP modulates mu opioid receptor alternative splicing via hnRNPH
    Meeting Abstract

    Xu, J.; Lu, Z.; Xu, M.; Pan, L.; Deng, Y.; Xie, X.; Hurd, Y. L.; Pasternak, G. W.; Cartegni, L.; Zhou, W.; more...
    Society for Neuroscience Abstract Viewer and Itinerary Planner (2013)

    Fulltext@MSK | Save
  • Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS signaling
    Meeting Abstract

    Will, M.; Toy, W.; Yao, Z.; Poulikakos, P.; Rodrik-Outmezguine, V. ; Schneider, C.; Paul, J.; Baselga, J.; Liu, N.; Rosen, N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Crizotinib, a selective c-Met inhibitor, prevents metastasis to the liver and lungs in a primary uveal melanoma mouse model
    Meeting Abstract

    Surriga, O.; Vinagolu, R.; Ambrosini, G.; Schwartz, G.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Metabolic characterization of prostate cancer cell lines
    Meeting Abstract

    Moroz, E.; Blasberg, R.; Serganova, I.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save